Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ventripoint Diagnostics Ltd (OP: VPTDF )

0.0650 -0.0247 (-27.54%)
Streaming Delayed Price Updated: 3:43 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ventripoint Diagnostics Ltd

Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital... 
Via TheNewswire.com
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st... 
Via TheNewswire.com
Ventripoint Announces Patent Application for Improved Heart Analysis
Toronto, Ontario – TheNewswire – August 09, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
Toronto, Ontario – TheNewswire – July 5, 2021 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; (OTC:VPTDF) is pleased to announce that it has engaged Digital257... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
Toronto, Ontario – TheNewswire – July 2, 2021 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT) (OTC:VPTDF) announces that on July 1, 2021 the Board of Directors... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
Ventripoint Also Provides a Financial Update 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint update on its Financial Status and on Warrant and Option Exercises
Toronto, Ontario – TheNewswire – May 6, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
Toronto, Ontario – TheNewswire – May 4, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
Toronto, Ontario - The Newswire - April 27, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) announces the Company has entered into a collaboration with GE... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
Toronto, Ontario – TheNewswire – April 20, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
Toronto, Ontario - The Newswire - April 19, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has filed a U.S. provisional patent application for its novel... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence COVID-19 Intellectual Property
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
Toronto, Ontario – TheNewswire – April 15, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce its sponsorship of the 2021 Canadian... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
Toronto, Ontario – TheNewswire – April 13, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has published its first case study of the meritorious use of the... 
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.